A recent study in the Journal of Atherosclerosis and Thrombosis reveals that serum levels of oxidized low-density lipoprotein (oxLDL) can predict 10-year progression of sub-clinical atherosclerosis, and that this is independent of the cholesterol content, the number and size of LDL particles.
Hanna Ritzén, R&D Managing Director at Mercodia shares her thoughts in this interview from Bioanalysis Zone. What are our challenges working with biomarker assays? And what does the future hold for the validation of biomarkers?
The Mercodia Bovine Insulin ELISA (10-1201-01) is, as the name suggests, optimized for bovine samples; however, researchers from Cleveland State University and Cleveland Metroparks Zoo recently used it to measure insulin levels in Masai giraffe.
How does one choose which glucagon assay to use? What is important to think about regarding sensitivity, matrix interference and cross-reactivity?
Find answers to these questions:
The prevalence of childhood obesity has increased worldwide in the past decades, which has been accompanied by a rise in obesity-related comorbidities such as type 2 diabetes mellitus (T2DM).
Mercodia's Bioanalytical Service provides you with the experience, quality and reliability that are fundamental to a productive partnership. Our experienced team of managers, scientists, technicians and regulatory resources will support you in everything from study design to sample handling. We follow the most recent international guidelines and industry standard white papers for bioanalytical method development and validation.
Our combined expertise will ensure that your studies of PK, PD and biomarkers are performed with the highest possible measurement quality, enabling you to make informed decisions based on accurate bioanalytical data. We are highly flexible in the transfer of data in different formats, to meet individual sponsor needs.
LOOK INSIDE FOR ANSWERS TO THESE QUESTIONS:
Exploring Frontiers in Translational Research
Learn about scientific advances that lead to a better understanding of diseases and therapies. Interviews with scientists and clinicians will provide you with cutting-edge information, coming directly from the source. Explore topics ranging from drug discovery and new FDA regulations to novel approaches to metabolic diseases (e.g., diabetes and heart disease).
At Mercodia, we pride ourselves on providing our customers with quick, accurate support. Below you will find answers to some common questions. If you do not find what you are looking for, please feel free to contact us: contacts
Our professional and experienced Customer Service and Technical Support teams are dedicated to ensuring complete customer satisfaction.